Avricore Health Inc
🇨🇦XTSX.AVCRCanadaHealthcare
PriceCA$0.060.00 (0%)
Latest anomalies
Negative 1 detected in the last 120 days
- High: 10
- Medium: 2
- Low: 0
Realized volatility: a breakout above its trailing average
Capital expenditure to revenue: a sudden spike above its trailing quarter average
Cash conversion cycle: a sudden spike above its trailing quarter average
Days inventory outstanding: a sudden spike above its trailing quarter average
Days sales outstanding: a sudden spike above its trailing quarter average
Free with a Finzer account.
Profile
- Healthcare
- Diagnostics & Research
- Canada
Identity
- Exchange
- TSX Venture Exchange . XTSX
- Type
- Stock
- ISIN
- CA0545211090
- CUSIP
- 054521109
Company
- Employees
- 0
- Headquarters
- Vancouver, Canada
- Website
- https://avricore.com
Market
- Shares outstanding
- 101.3M
- Market cap
- CA$6.08M
Highlights
No high and low reported for today's session.
- Market cap
- CA$6.08M
- EPS LTM
- -CA$0.01calculatedCalculated by Finzer, not reported by the data provider.
- P/E LTM
- -4.26calculatedCalculated by Finzer, not reported by the data provider.
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- CA$3.08M-31.23%down year on year
- Net income
- -CA$1.43M-48,817.64%down year on year
- Gross margin
- 42.97%+18.84%up year on year
- Free cash flow
- CA$230.39K+138.41%up year on year
Latest news
News is not sourced for this exchange.
Business summary
Avricore Health Inc is a company in the healthcare sector, listed on TSX Venture Exchange (Canada) under the ticker AVCR. Its market capitalisation is CA$6.08M, from 101.3M shares outstanding, as of . Across the 245 trading sessions to the shares traded between CA$0.05 and CA$0.10, and the last close of CA$0.06 sits 20% of the way up that range. The company is headquartered in Vancouver, Canada.
Avricore Health Inc. engages in the health data and point-of-care technologies business. It provides HealthTab, a turnkey point-of-care testing platform for pharmacies that can test up to 27 biomarkers on the spot for screening and managing chronic conditions, such as diabetes. The company was formerly known as Vanc Pharmaceuticals Inc. and changed its name to Avricore Health Inc. in October 2018. Avricore Health Inc. was founded in 1996 and is based in Vancouver, Canada.